Document Detail


Gallstones in obesity and weight loss.
MedLine Citation:
PMID:  11192327     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The prevalence of cholesterol gallstones is increased in obese persons. The risk is especially high in those with the highest body mass index (relative risk 5-6). Weight loss further increases the risk of gallstones: the prevalence of new gallstones reaches 10-12% after 8-16 weeks of low-calorie diet and more than 30% within 12-18 months after gastric by-pass surgery. About one-third of the stones are symptomatic. The increased prevalence of stones is mostly due to supersaturation of bile with cholesterol, because of an increased synthesis by the liver and secretion into bile. Saturation is further increased during weight loss. It returns toward normal after weight stabilization at a lower level, allowing spontaneous stone dissolution in some cases. Identified risk factors for gallstones during weight loss are a relative loss of weight greater than 24% of initial body weight, a rate of weight loss greater than 1.5 kg per week, a very low calorie diet with no fat, a long overnight fast period and a high serum triglyceride level. Ursodeoxycholic acid decreases cholesterol saturation of bile and gallstone incidence during weight loss. Other preventive measures include a control of weight loss rate, a reduction of the length of overnight fast, and maintenance of a small amount of fat in the diet.
Authors:
S Erlinger
Related Documents :
25080537 - A dietary biomarker approach captures compliance and cardiometabolic effects of a healt...
6811477 - Vitamin c in the control of hypercholesterolemia in man.
22674717 - Consumption of a high-fat diet, but not regular endurance exercise training, regulates ...
7956607 - Effects of octreotide on biliary lipid composition and occurrence of cholesterol crysta...
17095907 - Simultaneous low-density lipoprotein-c lowering and high-density lipoprotein-c elevatio...
15769987 - Effects of diet and exercise on muscle and liver intracellular lipid contents and insul...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  12     ISSN:  0954-691X     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2001-01-15     Completed Date:  2001-04-05     Revised Date:  2009-10-16    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1347-52     Citation Subset:  IM    
Affiliation:
Service d'Hépatologie and INSERM U-481, H pital Beaujon, France. serge.erlinger@bjn.ap-hop-paris
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Body Mass Index
Cholelithiasis / diagnosis,  epidemiology*
Comorbidity
Diet, Fat-Restricted
Female
Humans
Male
Obesity / diagnosis,  epidemiology*,  therapy
Prevalence
Prognosis
Risk Assessment
Weight Loss

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fat and gastro-oesophageal reflux disease.
Next Document:  Control of vascular tone in the syndromes of Bartter and Gitelman.